EGFR and cancer: These anti-EGFR doxorubicin-loaded immunoliposomes (anti-EGFR ILs-dox) displayed highly efficient binding and internalization in a panel of EGFR or EGFRvIII overexpressing cancer cell lines, as indicated by fluorescence microscopy and fluorescence-activated cell sorter.17